It could be a faulty LiPo that needs to be retired, an overcharging issue, or simply charging too quickly
doi: 10.1159/000125652 247 KojimaMHosodaHDateYNakazatoMMatsuoHKangawaK
A: There's no strong human evidence that it directly "burns fat" through thermogenesis or lipolysis pathways, the way true fat-loss drugs aim to do
Tirzepatide is a GIP and GLP-1 receptor agonist, meaning it activates two gut-hormone receptor pathways involved in glucose regulation and appetite
Safety begins with proper screening, including evaluation of kidney function, glucose-6-phosphate dehydrogenase status, and a review of medications and medical history
Potential Interactions Between Berberine and GLP-1 Therapy The primary concern when combining berberine with semaglutide or other GLP-1 medications is cumulative effect on insulin and blood glucose levels